Pay in 4 interest-free payments of $7.07 Learn more
Ships within 48 hours · Estimated delivery Aug 12 - Aug 17
Gastrointestinal effects: the main titration bottleneck Nausea, diarrhea, constipation, and vomiting run around 40 to 44% overall, dose-dependent in how many people report them but mild-dominant in severity: severe events stay at or below about 1.7% in any category even at the top dose. In the obesity program the by-dose rates run nausea 25/29/28%, diarrhea 19/21/23%, and vomiting 8/11/13% at 5/10/15 mg. They concentrate during escalation and ease with time on a held dose
Scientific Backing: Supplement selections are grounded in published clinical studies and current nutritional guidelines
Nutrition guidance and check-ins keep you on track and comfortable
Effects of psilocybin-assisted therapy on major depressive disorder: a randomized clinical trial
